Preoperative and intraoperative tirofiban during endovascular thrombectomy in large vessel occlusion stroke due to large artery atherosclerosis
European Journal of Neurology2024Vol. 31(10), pp. e16419–e16419
Citations Over TimeTop 10% of 2024 papers
Zhiqiang Sun, Shuhan Huang, Wěi Li, Yi Yang, Ya Wu, Xue Ma, Ximing Nie, Wang‐Sheng Jin, Chengchun Liu, Xiaoshu Li, Yaning Xu, Jun Dong, Yisi Liao, Binlu Sun, Wenjun Han, Qing Zhao, Huaqiao Chi, Yan‐Jiang Wang, Liping Liu, Meng Zhang
Abstract
Tirofiban shows good adjuvant therapy potential in acute ischemic stroke-LVO due to LAA patients. PT is associated with higher rates of EPR and better therapeutic efficacy. In addition, EPR may be a potential way to improve prognosis.
Related Papers
- → Safety and Functional Outcome of Thrombolysis in Dissection-Related Ischemic Stroke(2011)151 cited
- → Impact of Admission Glucose and Diabetes on Recanalization and Outcome after Intra-Arterial Thrombolysis for Ischaemic Stroke(2012)67 cited
- → Intra-Arterial Thrombolysis vs. Standard Treatment or Intravenous Thrombolysis in Adults with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis(2013)44 cited
- → Relationship between Post-Thrombolysis Blood Pressure and Outcome in Acute Ischemic Stroke Patients Undergoing Thrombolysis Therapy(2017)10 cited
- → Effectiveness of tirofiban for failed thrombolysis during acute myocardial infarction(2004)3 cited